Organisation paid for research Program year 2023 Source: CMS Open Payments

J&S Studies, inc.

Neither a doctor nor a teaching hospital

Research payments

$360,600

11 payments

Through program year 2023, J&S Studies, inc. is reported as receiving $360,600 in research payments, across 11 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$92,075	5
2022	Research	$3,500	1
2020	Research	$39,550	1
2019	Research	$225,475	4

Breakdown

Who paid Research payments · program years 2019–2023

Teva Pharmaceuticals USA, Inc. $265,025 5 payments
Journey Medical Corporation $95,575 6 payments

Studies the money was for Research payments · program years 2019–2023

A Randomized, Double Blind, Parallel Group, Three Arm, Placebo Controlled, Multi-Site Therapeutic Equivalence Study With Clinical End-points Comparing Test Product "Oxymetazoline Hydrochloride Cream, 1%" to Reference Product "RHOFADETM Cream, 1%" in the Treatment of Moderate to Severe Persistent Facial Erythema of Rosacea $265,025 5 payments
Dfd-29-Cd-005 $74,150 4 payments
Dfd-29-Cd-004 $21,425 2 payments

What the money was spent on Research payments · program years 2019–2023

Patient care $3,500 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.